Clinical Trial Update: Strategy of UltraProtective Lung Ventilation With Extracorporeal CO2 Removal for New-Onset Moderate to seVere ARDS [Phase 1, Phase 2]

View source ↗

Summary

This report covers a Phase 1/2 trial evaluating ultra-protective lung ventilation with extracorporeal CO2 removal for new-onset moderate to severe acute respira…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Snippet

Sponsor: European Society of Intensive Care Medicine | Conditions: Moderate Acute Respiratory Distress Syndrome | Phase 1, Phase 2 | Status: COMPLETED